Insight Molecular Diagnostics Inc. (IMDX) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 10.29M USD | Liabilities, Current |
| Cash and equivalents | 17.76M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 192.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 207.00K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $10.29M | $17.76M | (m) | $192.00K | $207.00K | (m) |
| 2026-03-31 | (m) | $12.01M | $28.20M | (m) | $157.00K | $382.00K | (m) |
| 2025-12-31 | (m) | $12.07M | $11.58M | (m) | $1.13M | $446.00K | (m) |
| 2025-09-30 | (m) | $7.66M | $18.69M | (m) | $258.00K | $471.00K | (m) |
| 2025-06-30 | (m) | $6.65M | $24.29M | (m) | $512.00K | $693.00K | (m) |
| 2025-03-31 | (m) | $9.68M | $31.03M | (m) | $3.54M | $459.00K | (m) |
| 2024-12-31 | (m) | $7.28M | $8.64M | (m) | $1.61M | $410.00K | (m) |
| 2024-09-30 | (m) | $9.09M | $3.36M | (m) | $209.00K | $232.00K | (m) |
| 2024-06-30 | (m) | $7.20M | $9.26M | (m) | $85.00K | (m) | (m) |
| 2024-03-31 | (m) | $8.33M | $5.58M | (m) | $161.00K | (m) | (m) |
| 2023-12-31 | (m) | $7.19M | $9.43M | (m) | $484.00K | (m) | (m) |
| 2023-09-30 | (m) | $8.03M | $13.78M | (m) | $1.88M | (m) | (m) |
| 2023-06-30 | (m) | $7.67M | $17.37M | (m) | $1.72M | (m) | (m) |
| 2023-03-31 | (m) | $9.43M | $11.80M | (m) | $1.90M | (m) | (m) |
| 2022-12-31 | (m) | $12.11M | $19.99M | (m) | $2.01M | (m) | (m) |
| 2022-09-30 | (m) | $12.95M | $32.05M | (m) | $1.99M | (m) | (m) |
| 2022-06-30 | (m) | $14.15M | $44.84M | (m) | $1.80M | (m) | (m) |
| 2022-03-31 | (m) | $13.96M | $20.41M | (m) | $2.12M | (m) | (m) |
| 2021-12-31 | (m) | $14.12M | $35.60M | (m) | $1.44M | (m) | (m) |
| 2021-09-30 | (m) | $13.38M | $43.34M | (m) | $1.03M | (m) | (m) |
| 2021-06-30 | (m) | $19.77M | $46.47M | (m) | $1.02M | (m) | (m) |
| 2021-03-31 | (m) | $9.69M | $58.91M | (m) | $703.00K | (m) | (m) |
| 2020-12-31 | (m) | $9.00M | $7.14M | (m) | $203.00K | (m) | (m) |
| 2020-09-30 | (m) | $8.90M | $10.29M | (m) | $366.00K | (m) | (m) |
| 2020-06-30 | (m) | $6.84M | $16.80M | (m) | $79.00K | (m) | (m) |
| 2020-03-31 | (m) | $6.93M | $16.58M | (m) | $13.00K | (m) | (m) |
| 2019-12-31 | (m) | $4.44M | $22.07M | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $3.04M | $19.44M | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $4.06M | $35.83M | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $3.20M | $39.26M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $5.56M | $8.03M | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $4.62M | $10.82M | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $4.49M | $10.29M | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $5.47M | $12.61M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $4.45M | $7.60M | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $4.64M | $11.02M | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $4.69M | $8.64M | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $4.55M | $11.35M | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $4.28M | $10.17M | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $3.97M | $12.67M | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $2.71M | $4.00M | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $2.75M | $5.86M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $2.31M | $8.00M | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | $9.41M | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | $2.40M | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | $82.00K | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $257.00K | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $101.00K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |